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Abstract
Background: A large proportion of people attending residential alcohol and other substance abuse treatment
have a co-occurring mental illness. Empirical evidence suggests that it is important to treat both the substance
abuse problem and co-occurring mental illness concurrently and in an integrated fashion. However, the majority of
residential alcohol and other substance abuse services do not address mental illness in a systematic way. It is likely
that computer delivered interventions could improve the ability of substance abuse services to address co-
occurring mental illness. This protocol describes a study in which we will assess the effectiveness of adding a
computer delivered depression and substance abuse intervention for people who are attending residential alcohol
and other substance abuse treatment.
Methods/Design: Participants will be recruited from residential rehabilitation programs operated by the Australian
Salvation Army. All participants who satisfy the diagnostic criteria for an alcohol or other substance dependence
disorder will be asked to participate in the study. After completion of a baseline assessment, participants will be
randomly assigned to either a computer delivered substance abuse and depression intervention (treatment
condition) or to a computer-delivered typing tutorial (active control condition). All participants will continue to
complete The Salvation Army residential program, a predominantly 12-step based treatment facility. Randomisation
will be stratified by gender (Male, Female), length of time the participant has been in the program at the
commencement of the study (4 weeks or less, 4 weeks or more), and use of anti-depressant medication (currently
prescribed medication, not prescribed medication). Participants in both conditions will complete computer sessions
twice per week, over a five-week period. Research staff blind to treatment allocation will complete the assessments
at baseline, and then 3, 6, 9, and 12 months post intervention. Participants will also complete weekly self-report
measures during the treatment period.
Discussion: This study will provide comprehensive data on the effect of introducing a computer delivered,
cognitive behavioral therapy based co-morbidity treatment program within a residential substance abuse setting. If
shown to be effective, this intervention can be disseminated within other residential substance abuse programs.
Trial registration: Australia and New Zealand Clinical Trials Register (ANZCTR): ACTRN12611000618954
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Background
It is very common for people with alcohol or substance
dependence disorders to also have other co-occurring
mental illnesses. This is particularly the case for people
attending residential alcohol and other substance abuse
treatment services, where it is estimated that between
64% and 71% of participants have co-occurring mental
illness [1]. When compared to people with a substance
abuse problem unaccompanied by mental illness, people
with co-occurring mental illnesses tend to have much
poorer treatment outcomes. For example, they are sig-
nificantly more likely to have a poor treatment response,
higher rate of relapse, more hospital visits, increased
incidence of Hepatitis C and HIV infection, higher
incarceration rate, family difficulties and homelessness
[see 2].
Traditionally, alcohol and other substance abuse ser-
vices have delivered drug and alcohol interventions and
relied on mental health services, working in either a par-
allel or sequential fashion, to address the mental health
of their patients [3,4]. This type of approach has proven
largely ineffective, often resulting in increased fragmen-
tation between the services, higher treatment dropout
and exclusion of participants from substance abuse ser-
vices [5]. In response, integrated approaches have been
developed that concurrently target both the substance
abuse and mental illness [see 3 review]. There is evi-
dence that integrated residential treatment facilities are
more effective in treating complex mental illness and
substance abuse disorders, than less integrated facilities
[2].
Cognitive Behavioural Therapy (CBT) is an approach
that lends its self very successfully to being delivered in
an integrated fashion. There is strong support for its
effectiveness in the treatment of alcohol and substance
abuse disorders [6], as well as across a wide range of
psychiatric conditions [7]. Whilst CBT has demonstrated
comparative effectiveness to other therapeutic
approaches [8], it tends to have more durable long-term
effects when compared to other treatment conditions
[9]. For example, in a randomized trial comparing inte-
grated CBT with a12-Step facilitation therapy for people
diagnosed with substance dependence and depression,
both interventions produced similar reductions in sub-
stance use and depression at the end of treatment [10].
However, participants in the integrated CBT condition
continued to demonstrate improvements in their
depression at 6-months follow-up, while depression for
participants in the 12-Step condition deteriorated. More
stable reductions in substance use were also demon-
strated for people in the integrated CBT condition at
follow-up.
Whilst there is increasing empirical support for inte-
grated treatment approaches, the majority of substance
abuse services do not address co-occurring mental ill-
ness in a systematic way. For example, a review of resi-
dential substance abuse services across three Australian
states indicated that 88% of services were not equipped
to provide integrated mental health treatment [11]. This
appears to be largely the result of organisations employ-
ing people with limited or no mental health qualifica-
tions and failing to prioritise co-morbidity treatment
[12]. Moreover, high staff turnover rates in the sub-
stance abuse field [13,14] makes attempts to train staff
in new therapeutic approaches, such as integrated CBT,
problematic and difficult to sustain in the longer term.
One approach to improve the utilization of evidence-
based approaches in health settings is to use computer
based interventions [15]. Benefits of computer based
approaches are that they do not require additional staff,
do not rely on staff having specialist mental health or
substance abuse training, and are relatively cost-efficient
to deliver. Emerging research has demonstrated that
computer delivered interventions can produce clinically
significant improvements across a range of outcome
domains [16]. Computer delivered interventions are
increasingly being recommended for use in the sub-
stance abuse field [17-21]. Whilst it is still a developing
area of clinical research, the use of computer based CBT
interventions for drug and alcohol abuse appears to be
efficacious [22]. For example, CBT4CBT is a 6-session,
computer-delivered program that is based on cognitive
behavioural principles. It is a self-directed program that
is used as an adjunct to treatment as usual. Evaluation
of the program indicated that it is superior to treatment
as usual, both at the end of treatment, and at 8-weeks
and 6-month follow-up [23,24]. Whilst CBT4CBT
appears to be quite a promising intervention, it does not
specifically target co-occurring mental illnesses.
An integrated computer delivered CBT intervention
for co-occurring depression and alcohol or substance
use disorders has been developed. The Self-Help for
Alcohol/other drug use and Depression program
[SHADE; 25] is a 10-session multimedia psychotherapy
treatment program incorporating motivational, beha-
vioural and cognitive components. The SHADE program
delivers its therapeutic content via a number of interac-
tive components including video demonstrations, voice-
overs, and in session exercises. Results from an initial
randomised clinical trial indicated that the SHADE Pro-
gram outcomes were equivalent when a therapist deliv-
ered the same intervention to people attending
outpatient substance abuse treatment. It also produced
significantly better treatment outcomes than a brief
intervention alone [25]. To date research has not exam-
ined the use of SHADE within a residential treatment
setting or the extent that it might enhance standard
care [26].
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The current project will be conducted at The Salva-
tion Army Sydney Recovery Service Centres located in
the Australian states of Sydney and Brisbane. These cen-
tres provide a 12-step based residential alcohol and
other substance abuse program. The purpose of the cur-
rent study is to examine the effectiveness of ‘adding’ the
SHADE program to an already established treatment
facility. The study will be conducted as a randomized
trial, in which participants allocated to the treatment
condition will complete the SHADE Program. A typing
training program will be used as an active control con-
dition. As mental illness is not specifically targeted as
part of The Salvation Army program, and CBT is not
systematically available for substance use disorders, it is
hypothesized that individuals in the Treatment Condi-
tion will report greater improvements in their mental
health and greater reductions in their substance use at
follow-up, than individuals in the Control Condition.
Recruitment for the study is currently underway. The
study is funded by a competitive research grant from
the Australian Rotary Health Fund. The University of
Wollongong Human Research Ethics Committee (HE11/
091) has approved the research trial, which is registered
with the Australian New Zealand Clinical Trials Registry
(ACTRN12611000618954).
Methods/Design
Study setting
The research program is being conducted at two sites,
the Sydney Recovery Service Centre and the Brisbane
Recovery Service Centre. The Australian Salvation Army
operates both of these centres. The treatment program
is up to 10-months in length and is operated in the
form of a modified therapeutic community. The Sydney
service has 102 beds, including 82 for males and 20 for
females. The Brisbane service has 84 beds, including 72
for males and 12 for females. All participants are
required to be over the age of 18 and must have an
alcohol, substance abuse or gambling problem.
Study design
This is a prospective randomised controlled trial. Figure
1 shows the design of the study. After completion of a
baseline assessment, participants will be randomly
assigned to either the treatment condition (i.e. computer
delivered integrated substance abuse and mental health
intervention; SHADE) or an active Control Condition (i.
e. computer delivered typing tutorial program; Type
Master Pro). Randomization will be stratified by gender
(male and female), length of time the person has been
in the program (4-weeks or less, 4-weeks or more) and
current use of anti-depressant medication (currently tak-
ing anti-depressant medication, not taking anti-depres-
sant medication). Following completion of the baseline
assessment for each participant, the researchers will be
issued with a sealed randomisation envelope by an inde-
pendent researcher that displays the participant identifi-
cation code. Participants will be instructed to open the
envelope at the conclusion of the initial assessment. A
permuted block randomisation approach will be used so
that the distribution of participants across treatment
conditions will be maintained regardless of the final
sample size.
Participants
All participants will be attending either the Sydney or
Brisbane Recovery Service Centres. For the purpose of
the current study, only people diagnosed with an alcohol
or substance abuse problem will enter the study. It is
expected that over the course of the study approxi-
mately 200 people will be recruited to participate. Pre-
vious surveys of people attending Australian Recovery
Service Centres indicate that on average participants are
37 years of age (SD = 9.90) and have had long-term sub-
stance abuse problems (M = 19 years; SD = 23.10). On
average, alcohol is the most commonly reported primary
substance of abuse (55.6%), followed by amphetamines
(20.8%), cannabis (9.7%), heroin (6.2%) and others [7.7%;
[27]]. All participants will complete informed written
consent prior to commencing the study, and all partici-
pants will be over the age of 18.
Inclusion and exclusion criteria
All participants attending the residential program will be
approached to participate in the study. Exclusion criteria
have been kept to a minimum to ensure that the study
can examine the effectiveness of using the SHADE pro-
gram within a ‘real world’ setting. Participants will only
be excluded from the study if: a) the person did not
satisfy the diagnostic criteria of an alcohol or substance
dependence disorder (i.e. people who were attending the
Recovery Service Centre for only gambling). b) The per-
son is a non-English speaker or has a low level of lit-
eracy or an organic brain disease that would impact the
persons understanding of the computer interventions.
Participants will be included in the study even if they
do not have a current or previous diagnosis of a depres-
sive disorder. This decision was made for four reasons:
a) approximately 80% of participants attending The Sal-
vation Army Recovery Service Centres report a lifetime
history of symptoms associated with depression [1]. Sub-
sequently, people with alcohol and substance abuse dis-
orders are at risk of developing depression; b)
Individuals with substance abuse disorders typically
experience high levels of depressotypic thoughts [28]; c)
Previous research shows that symptoms of depression at
follow up rather than a diagnosis of a mood disorder at
intake is associated with relapse following treatment for
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substance use disorders [29] and; d) it is expected that
participants without symptoms associated with depres-
sion would still benefit from the substance abuse com-
ponent of the intervention. To account for the potential
confound of depressive disorders participants will be
stratified based on their current use of anti-depressant
medication as part of the randomization procedures.
Interventions
Treatment Condition (computer based co-morbidity
treatment)
Individuals in this condition will complete the SHADE
program [25]. Participants will attend two × 1-hour ses-
sions each week, completing the program in five-weeks
(approximately 10 h of engagement with SHADE in total).
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Recruit participants at The Salvation Army 
Recovery Service Centres 
Baseline Assessment 
Randomisation 
Computer delivered typing tutor  
(Active control) 
2 sessions per week, over a 5-week period  
(10 sessions in total) 
 + TAU 
n = 100 
Post treatment assessment 
(5 weeks) 
3, 6, 9, and 12-month follow-up 
 (Independent assessor) 
Computer delivered co-morbidity intervention 
(Treatment condition) 
2 sessions per week, over a 5-week period  
(10 sessions in total) 
 + TAU 
n = 100 
  
Post treatment assessment 
(5 weeks) 
3, 6, 9, and 12-month follow-up 
 (Independent assessor) 
Figure 1 Study design.
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These sessions will be conducted on computers located at
the Recovery Service Centre. Research assistants will pro-
vide technical support whilst participants are completing
the program (e.g. helping the person to become familiar
with using the program), but will not provide any clinical
support. The SHADE program is a clinical intervention
that incorporates aspects of motivational interviewing and
CBT. The program content is delivered in an integrated
fashion and is designed to encourage a reduction in
depression and alcohol and/or substance use. The pro-
gram contains interactive components, including video
demonstrations, voiceovers and in-session exercises. The
video components are viewed and model the cognitive and
behavioural skills relevant to the therapy (e.g. activity sche-
duling, self-monitoring of thoughts, challenging faulty cog-
nitions, identifying and evaluating cognitive schema,
drink/drug refusal and problem solving).
Active Control Condition (computer delivered typing tutor
program)
A limitation with previous computer based intervention
studies is the lack of an active control condition [22].
To address this concern we have included a computer
delivered typing tutor to control for the amount of
screen time participants in the treatment condition
experience. Participants in the active control condition
will complete a commercially available typing tutor pro-
gram [30]. This program has previously been used as an
active control in studies examining computer delivered
cognitive remediation for participants attending residen-
tial substance abuse services [31]. Participants will
attend two × 1-hour sessions each week, completing the
computer delivered typing program in 5 weeks (approxi-
mately 10 h in total). This is comparable to the Treat-
ment condition. These sessions will be conducted on
computers located onsite and, as with the Treatment
condition, research staff will be available to support par-
ticipants with the technical aspects associated with using
the computer program.
Treatment as usual (TAU)
Participants in both the Treatment and Control condi-
tions will be completing The Salvation Army Recovery
Service Centre program (i.e. TAU). The program utilises
a 12-Step approach and is primarily based on the dis-
ease model of addiction. Participants attend individual
case management, group therapy sessions and regular
chapel services. Groups provided during the program
cover a diverse and eclectic range of areas including
social skills training, relapse prevention planning, family
systems work and anger management. However, partici-
pants do not have access to cognitive behavioural ther-
apy. The program does not specifically address co-
occurring mental illness, although participants may be
under the care of an external medical practitioner and
be taking psychiatric medication.
Outcome measures
Baseline assessments will be conducted prior to notifica-
tion of randomization status. This will include adminis-
tering the Structured Clinical Interview of the DSM IV
[SCID; [32]] to identify 12-month and lifetime history of
alcohol or other substance abuse and dependence disor-
ders. Additionally, 12-month and lifetime history of
depressive disorders will also be assessed using the
SCID. Outcome measures will be collected at baseline,
weekly during the 5 weeks of the treatment program
and then at 3-, 6-, 9-, and 12-month follow-up (see
Table 1 for schedule). Independent assessors, who will
remain blind to intervention allocation, will conduct fol-
low-up telephone assessments to collect this data. Each
participant will be offered $20 AUD for completion of
the baseline assessment and each subsequent follow-up
assessment, as reimbursement for the time associated
with completing the measures. Participants will receive
$10 AUD for each assessment completed during the
treatment program. For assessments completed while a
participant is a resident at the Recovery Service Centre,
he or she will be remunerated in cash. For telephone
assessments completed once the participant leaves the
program, gift certificates will be mailed out.
Primary outcome measures
The two primary outcome variables will be: a) level of
substance use; and b) level of depression. The level of
substance use will be measured using the composite
scores for alcohol use and drug use from the Addiction
Severity Index - 5th Edition [ASI; [33]]. The ASI is a
semi-structured clinical interview that has been used
widely in addiction research [34]. The Opiate Treatment
Index [OTI; [35]] will be used as an alternate measure
of alcohol and substance use in the last month. The
OTI yields a score reflecting the mean number of sub-
stance use occasions per day for each drug class
assessed for the month prior to assessment. The Time-
line Follow-Back Method [TLFB; [36]] will be used to
improve participants’ recall of their alcohol and sub-
stance use on the ASI and OTI. The TLFB method
yields high test-retest reliability and has been used suc-
cessfully in both face-to-face and telephone delivered
assessment procedures [37,38]. The Beck Depression
Fast Screen [BDFS; [39]] and the depression subscale of
the Depression, Anxiety and Stress Scale [DASS-21;
[40]] will be used to examine changes in depression
levels during the course of the study.
Secondary outcome measures
A requirement of treatment in the residential facility is
that participants do not use any alcohol or non-pre-
scribed substances of abuse. Therefore, to be able to
examine alcohol and substance use outcomes whilst a
person is a resident of the program, secondary outcome
measures will be included that examine cravings for the
Kelly et al. BMC Public Health 2012, 12:113
http://www.biomedcentral.com/1471-2458/12/113
Page 5 of 9
person’s primary substance of abuse [PENN Alcohol
Cravings Survey; [41]] and self-efficacy in terms of
resisting the urge to drink alcohol or take drugs in spe-
cific high relapse risk situations [Drug Taking Confi-
dence Questionnaire; [42]]. Additionally, the
Dysfunctional Attitudes Scale [43] will be used to exam-
ine changes in the existence and intensity of dysfunc-
tional attitudes commonly associated with depression.
The ASI composite score for employment status will
also be used to examine employment outcomes.
To examine the potential mechanisms of change asso-
ciated with the SHADE program, two measures of cop-
ing skill acquisition will be included. The Drug Risk
Response Test [DRRT; [44,45]] measures coping skills to
manage circumstances in which there is a high risk for
using alcohol or other drugs. It has been used in a num-
ber of studies exploring coping skill acquisition amongst
individuals receiving treatment for substance use disor-
ders [45-47]. The Ways of Responding Questionnaire
[WOR; [48]] is a measure that examines coping skills in
response to situations that increase the risk of depressed
mood. Both the DRRT and the WOR involve the parti-
cipant providing responses to hypothetical scenarios,
with their responses providing an indication of both
their adaptive and maladaptive coping skills. Research
assistants blind to the participants treatment condition
will rate both the WOR and the DRRT.
Data-analysis
Power analysis
Data from the SHADE study [25] indicate that the com-
puterized intervention is associated with a 1.53 effect
size change for depression and 0.86 for alcohol between
baseline and 12-month follow-up assessments. These
effects sizes were entered into G-Power 3.1 [49] in order
to estimate the sample sizes required to detect similar
differences between the treatment and active control
conditions in the current study. Power was set at 80%
and conservative 2-tailed tests were assumed even
though a directional hypothesis is proposed. The sample
size needed to detect a similar effect size between
groups on depression is 8 per group for depression
(total N = 16) and 23 per group for alcohol (total N =
46). Given the SHADE studies compared the computer-
ized intervention to a control condition consisting of
only received a brief intervention and the proposed
study is comparing SHADE + TAU to an active control
condition + TAU, we anticipate smaller effect sizes.
When a more conservative medium effect size of .50 is
used, power is set to 80% and a 2-tailed test is used, a
Table 1 Assessment instruments proposed for the current study
Domain assessment and instrument used Baseline Weeks Week Months
1 to 4 5 3, 6, 9,12
Diagnostic Assessment
Structured Clinical Interview for DSM Disorders: depression and substance abuse sections only ✓
Alcohol and substance abuse measures
Addiction Severity Index: Alcohol and Drug composite scores ✓ ✓ ✓
Alcohol Use Disorders Identification Test ✓
Drug Abuse Screening Test ✓
Opiate Treatment Index ✓ ✓ ✓
Drug Taking Confidence Questionnaire ✓ ✓ ✓ ✓
PENN Alcohol Craving Scale ✓ ✓ ✓ ✓
Drug Risk Response Test ✓ ✓
Fagerstrom Test for Nicotine Dependence ✓ ✓ ✓ ✓
Mental health measures
Addiction Severity Index: Mental Health composite score ✓ ✓ ✓
Depression, Anxiety and Stress Scale ✓ ✓ ✓ ✓
Beck Fast Screen ✓ ✓ ✓ ✓
Dysfunctional Attitudes Scale ✓ ✓ ✓ ✓
Ways of Responding ✓ ✓
Other
Background and demographic information ✓
Addiction Severity Index: Employment Status composite score ✓ ✓
Client Satisfaction Survey ✓
Computer Attitudes Scale ✓ ✓ ✓
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sample size of 64 per group is needed (total N = 128). A
conservative drop out rate is 35% of participants at fol-
low-up. As such, we will recruit a minimum of 200 par-
ticipants to the study. This will ensure that we will have
sufficient power to conduct the analysis.
Analysis plan
Data coding and analysis will be carried out by the
authors using available software packages. Variables
hypothesised to change over time according to treat-
ment allocation will be examined predominantly using
generalized linear mixed models. These techniques facil-
itate management of missing data without imputing
values or excluding participants. Primary outcome mea-
sures will typically be analysed in two ways: a) intention
to treat; and b) analyses performed within the sub-sam-
ple of participants who completed the majority of treat-
ment sessions. In addition, comparisons on selected
demographic and clinical characteristics will be made
between this sub-sample and those who dropped out of
treatment, to help detect any biases in outcome mea-
sures. Other potential confounders will also be exam-
ined (e.g. involvement in additional mental health
treatments) and their potential effects will be modelled
in the major analyses (e.g., controlling and not control-
ling for these variables). As a partial control for the
number of statistical tests to be conducted, the thresh-
old for significance will be set at p < 0.01.
Discussion
The present study is examining the effectiveness of ‘add-
ing’ a computer delivered co-morbidity intervention to
residential alcohol and other substance abuse treatment.
A large proportion of people accessing residential drug
and alcohol treatment screen positive for mental illness,
with depression being the most common [1]. It is
expected that long-term mental health outcomes for
participants who complete the SHADE program will be
significantly better than for those allocated to the con-
trol condition. Additionally, as the residential treatment
facility is based on a 12-step approach, rather than a
CBT approach, it is expected that the CBT based
SHADE intervention will also improve alcohol and sub-
stance abuse outcomes for participants relative to the
control condition.
Strengths and limitations
A significant strength of the current research is that it
will be conducted as an effectiveness study. Unlike effi-
cacy studies, where clinical trials are typically conducted
in highly controlled research environments, effectiveness
studies are conducted in ‘real world’ treatment settings.
The advantage of using this approach is that the results
are more representative of ‘actual’ clinical practice and
provide evidence regarding the feasibility of using the
intervention as part of ongoing routine care. The
research design also includes additional attempts to
increase the generalizability of the results by using very
inclusive eligibility criteria.
Previous trials of the SHADE program have used
therapists to support the delivery of the program
[25,26]. This has included the delivery of a one-session
intervention at the commencement of treatment and
10-minute ‘check in’ sessions at the conclusion of each
computer session. Possible advantage of such an
approach are that therapists can check participants
understanding of the intervention, confirm homework
assignment, and therapists can address any motivational
issues. It has been suggested that therapist support is
likely to improve client utilisation of computer interven-
tions and subsequently improve client outcomes [18].
However, a decision has been made in this study to not
provide therapist support in the delivery of the program.
This is in line with previous computer delivered inter-
ventions for substance abuse clients [44] and likely
reflects more closely how interventions would ultimately
be implemented within routine care.
A further strength is that the research design includes
an active attention control condition. A computer deliv-
ered typing tutor will be used as the control, with parti-
cipants being provided with the rationale that improving
their typing skills will help their future employment
opportunities. This active control has previously been
used in computer based trials in residential alcohol and
other substance abuse treatment settings [31], and
addresses limitations with previous clinical trials in
which comparisons have only been made to no-treat-
ment conditions [22].
A significant challenge for this project will be partici-
pant dropout due to participants leaving the residential
treatment facility prior to completing the intervention.
Dropout rates from substance abuse treatments are
extremely high. Fifty-seven percent of participants pre-
maturely leave within the first 3-months of treatment
[50]. Similar percentages have also been reported in the
broader alcohol and other substance abuse treatment lit-
erature [see [51] for review]. To help address this con-
cern, participants will complete the SHADE or
computer delivered typing interventions twice a week (i.
e. over a 5-week period). This represents a shift from
the protocol used by Kay-Lambkin et al. [25], where
SHADE was delivered weekly for 10-weeks.
A further challenge for the study will be retaining par-
ticipants at follow-up. People with alcohol and other
substance abuse disorders are traditionally very difficult
to follow-up. This is further complicated with residential
facilities, as participants often move outside of their
local area to attend treatment. Attempts to improve fol-
low-up rates in the current study will include using
Kelly et al. BMC Public Health 2012, 12:113
http://www.biomedcentral.com/1471-2458/12/113
Page 7 of 9
telephone follow-up, obtaining contact details of signifi-
cant others to help with locating participants, reinfor-
cing to participants the importance of conducting
follow-up and financially compensating participants for
the time required to complete the assessments (AUD
$20).
Conclusion
To our knowledge this is the first study to examine the
use of a computer based comorbidity intervention
within a residential substance abuse setting. The current
study seeks to address a significant gap in treatment
delivery by examining the effectiveness of using a com-
puter-based comorbidity intervention, employing CBT
strategies, within a residential substance abuse setting.
Results from this study will provide very valuable infor-
mation regarding effectiveness of ‘adding’ the SHADE
program to routine care. The study will also provide
information regarding the feasibility of using computer
delivered interventions within residential alcohol and
other substance abuse settings.
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